Literature DB >> 407326

Single radial immunodiffusion test for detecting antibodies against surface antigens of intracellular and extracellular vaccinia virus.

V J Prakash, E Norrby, L Payne.   

Abstract

Antibodies to surface antigens of intracellular naked vaccinia virus (INV) and in limited studies extracellular enveloped virus (EEV) were determined by single radial immunodiffusion tests (SRDT) with immobilized virions in agarose gels. Antibodies to INV were demonstrable in rabbit hyperimmune sera (one to four visible zones), smallpox convalescent sera and sera from re-vaccinated individuals. A difference in specificity of antibodies reacting with INV and EEV was detectable by SRDT. The SRDT provides a simple, reproducible and specific test for detection of antibodies against vaccinia or variola virus, but the technique requires large quantities of virions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 407326     DOI: 10.1099/0022-1317-35-3-463

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Immune response in rabbits to surface components of extracellular and intracellular forms of vaccinia virus.

Authors:  N Balachandran; P Seth; L N Mohapatra
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

2.  Polypeptide composition of extracellular enveloped vaccinia virus.

Authors:  L Payne
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

3.  Effect of glycosylation inhibitors on the release of enveloped vaccinia virus.

Authors:  L G Payne; K Kristensson
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

4.  Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus.

Authors:  L G Payne
Journal:  J Virol       Date:  1979-07       Impact factor: 5.103

5.  The existence of an envelope on extracellular cowpox virus and its antigenic relationship to the vaccinia envelope.

Authors:  L G Payne
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.